2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Glioblastoma
8
Neoplasms
4
Brain Neoplasms
4
Endometrial Neoplasms
3
Breast Neoplasms
3
Polycystic Ovary Syndrome
2
Pancreatic Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Pediatric Brain Tumor
1
Ovarian Neoplasms
1
Non-alcoholic Fatty Liver Disease
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Kidney Neoplasms
1
Ketogen-based Therapeutic Diet
1
Intermittent Fasting
1
Head and Neck Neoplasms
1
Growth Hormone-Secreting Pituitary Adenoma
1
Glioma
1
Fatty Liver
1
Estrogen Receptor-positive Breast Cancer
1
Drug Resistant Epilepsy
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Autism Spectrum Disorder
1
Adenocarcinoma of Lung
1
Interventions
aldesleukin
43
Sunitinib
42
Cyclophosphamide
30
Nivolumab
29
pembrolizumab
27
Everolimus
27
Interferon-alpha
25
Bevacizumab
23
Sorafenib
22
Interleukin-2
20
fludarabine phosphate
19
Radiotherapy
18
Ipilimumab
18
Filgrastim
18
Axitinib
18
Gene Expression Profiling
16
Peripheral Blood Stem Cell Transplantation
15
Gemcitabine
15
cabozantinib
14
Radiosurgery
13
fludarabine
11
Doxorubicin
11
Carboplatin
11
Blood Specimen Collection
11
temsirolimus
10
atezolizumab
9
Immunohistochemistry
9
Etoposide
9
Chemotherapy, Adjuvant
9
sargramostim
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Diet, Ketogenic
×
Clear all
NCT04316520
2024-08-16
CETOREIN
University Hospital, Angers
Phase NA
Completed
20 enrolled